Form 4 for GRDN Guardian Pharmacy Services, Inc.
Accepted 2025-09-30 00:00:00 ET · period of report 2025-03-28 · accession 0001193125-25-225032 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-09-30 | 2025-05-27+ | GRDN | Cardinal Equity Fund, L.P. | Member of 10% owner group | S - Sale+OE | $20.16 | -321.3K | 200.1K | -62% | -$6.48M |
| D | 2025-09-30 | 2025-09-27 | GRDN | Cardinal Equity Fund, L.P. | Member of 10% owner group | M - OptEx | — | +471.1K | 620.9K | +314% | — |
| D | 2025-09-30 | 2025-09-27 | GRDN | Cardinal Equity Fund, L.P. | Member of 10% owner group | M - OptEx | — | -471.1K | 942.1K | -33% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2025-05-28 | S | D | 50,305 | $20.16 | 149,794 | D | — | — | |
| 2 | Common | Class A Common Stock | 2025-09-27 | M | A | 471,057 | — | 620,851 | D | — | — | (F2) Pursuant to the Issuer's Amended and Restated Certificate of Incorporation, the Reporting Person's shares of Class B common stock automatically convert into shares of the Issuer's Class A common stock, on a one-for-one basis, in substantially equal tranches on each of September 27, 2025, March 28, 2026 and September 27, 2026. |
| 3 | Common | Class A Common Stock | 2025-05-27 | S | D | 270,958 | $20.16 | 200,099 | D | — | — | |
| 4 | Derivative | Class B Common Stock | 2025-09-27 | M | D | 471,057 | — | 942,114 | D | — · — to — | 471,057 Class A Common Stock | (F2) Pursuant to the Issuer's Amended and Restated Certificate of Incorporation, the Reporting Person's shares of Class B common stock automatically convert into shares of the Issuer's Class A common stock, on a one-for-one basis, in substantially equal tranches on each of September 27, 2025, March 28, 2026 and September 27, 2026. |